웹2024년 4월 10일 · The study is being conducted to evaluate VEGFR BP102 with nab-paclitaxe or treatment of physician's choice (TPC) versus nab-paclitaxe or TPC in patients for basal-like immune suppressed (BLIS) subtype of triple-negative breast cancer (TNBC) in the first-line teatment of unresectable locally advanced or metastatic TNBC. 웹2024년 6월 16일 · Subtype 3 was called basal-like (BL) due to increased proliferation and DNA damage-related genes, similar to the TNBCtype-6 BL subtype. Subtype 4, which exerted the worst prognosis, showed downregulation of cell growth and immune-related pathways and was identified as the Suppressed (S) subtype .
Triple-negative breast cancer and basal-like subtype - PubMed
웹2024년 10월 14일 · Patients with a basal-like subtype had worse OS (11 versus 16 months (HR 1.49, 95 per cent c.i. 1.03 to 2.15; P = 0.035)) than patients with a classical subtype. … 웹The TNBC subtypes are basal-like 1 (BL1), basal-like 2 (BL2), immunomodulatory ... Characterization of TNBC subtype cell lines. a Lysates prepared from cells grown for 48 h in medium ... lampara melt tom dixon
トリプルネガティブ乳癌の治療戦略 - 日本郵便
웹这2个分类方法: Perou's “PAM50” TNBC molecular classification (luminal A, luminal B, HER-2-positive, basal-like and normal-like subtypes) Lehmann/Pietenpol “TNBC Type” molecular … 웹In 104 biopsies, the luminal and HER2-enriched subtypes showed a high proportion of CEACAM6(+) tumors (78% and 83%, respectively); the basal … 웹2008년 11월 17일 · Lane’s research also showed that basal-like breast cancer cells are most like breast stem cells, which generate the tissues of the breast. One way they’re alike is that they are resistant to chemotherapy and do not express mature breast markers like estrogen receptors. These features make basal-like breast cancers so difficult to treat. jess jr \u0026 sons